GL1X · GenesisL1 explorer

MolNFT v1 · #160318 · protein

Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity

6PGX: “Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with…”. X-ray diffraction, 2 ligands (OJ4, ZN). MolNFT v1 #160318 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6PGX
Type
protein
Length
259 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P00918
Ligands
OJ4, ZN

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein259—P00918

Ligands and binding sites

  • OJ4 · 4-[(2S)-2-hydroxy-3-{[(2R)-2-hydroxy-3-(4-sulfamoylphenoxy)propyl]tellanyl}propoxy]benzene-1-sulfonamide · ligand · 3 copies · chains A
  • ZN · Zinc ion · metal · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6PGX · Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00918 · AlphaFold monomer V2.0 prediction for carbonic anhydrase 2 (P00918) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.